Analysis: Trump’s Prescription Drug Proposals Could Lower Drug Prices and Spending, but Does Not Directly Address Underlying Causes

Today, the Commonwealth Fund published a blog post on the President’s Budget proposals intended to address drug costs.

The Trump administration laid out a package of proposals to lower drug costs in the president’s budget for fiscal year 2019. As a package, the proposals could help decrease patient costs for drugs and reduce federal spending. Several individual proposals lower prices and were included in our report, Getting to the Root of High Prescription Drug Prices: Drivers and Potential Solutions. It’s hard to say how all the proposals taken together will affect prices, but it’s likely that more policies will be needed to control the drivers of drug spending. Here’s a closer look at the primary proposals, which would serve as encouraging first steps toward addressing drug costs.

While some of the president’s budget proposals would lower patient costs for prescription drugs and could alleviate growth in government spending for drugs, it is not a complete fix for lowering prescription drug prices. The administration and policymakers should consider focusing on policies that directly address the drivers of high prescription drug pricing.

Check out the full blog post here.

Real Change

Seize the moment. Send the message. Solve the problem. With Waxman, it’s all possible.

See Our Work